If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
31
Followers on Owler
Elixir
manufactures and markets medical devices and drugs for the treatment of cardiovascular diseases...
Read more
Overview
Competitors
Funding
News & Insights
Elixir
manufactures and markets medical devices and drugs for the treatment of cardiovascular diseases...
Read more
Founder & CEO
Motasim Sirhan
CEO Approval Rating
83/100
Weigh In
2005
Milpitas
California
San Francisco Bay Area
Private
Health Care Equipment & Services
Health Care Equipment
5047
NAICS listing
http://elixirmedical.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$5.3M
News
Latest News
Apr 11, 2025
Medical Device Network
Elixir: Elixir Medical debuts IVL system in Europe
Mar 18, 2025
Elixir Blog
Elixir Blog Elixir Medical Named to Fast Company's Annual List of the World's Most Innovative Companies of 2025
Feb 18, 2025
Pulse2.0
Elixir: Elixir Medical: Interview With Founder & CEO Motasim Sirhan About The Patient Care Company
Oct 30, 2024
Medical Device News Magazine
Elixir: Elixir Medical Reports | LithiX HC-IVL System Data Demonstrate Sustained Safety and Efficacy at Six Months
Oct 29, 2024
Drug Delivery Business
Elixir: Elixir Medical has positive data for drug-eluting bioadaptive implant
Oct 15, 2024
FinanzNachrichten
Elixir: Elixir Medical Corporation: TCT 2024: Elixir Medical to Present Clinical Outcomes on Two Transformative Platforms Designed to Advance Cardiovascular Disease Treatment and Intervention
Aug 29, 2024
Elixir Blog
Elixir Blog ESC Congress 2024: INFINITY-SWEDEHEART Trial of Elixir Medical's DynamX Bioadaptor Meets Primary Endpoint and Clinical Results Confirm Unique Mechanism of Action
Aug 13, 2024
FinanzNachrichten
Elixir: Elixir Medical Corporation: Elixir Medical to Present Late-Breaking One-Year Primary Outcomes from the 2,400 Patient INFINITY-SWEDEHEART Clinical Trial at ESC Congress 2024
Jun 19, 2024
Medical Device Network
Elixir: Elixir's DynamX bioadaptor obtains FDA breakthrough designation
May 16, 2024
FinanzNachrichten
Elixir: EuroPCR 2024: Primary Outcomes from PINNACLE I Clinical Trial Establish Safety and Effectiveness of Elixir Medical's Hertz Contact Intravascular Lithotripsy System for Calcium Fragmentation in Moderate to Severe Calcified Coronary Artery Lesions
Follow and Get Alerts
Elixir Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 9 + competitors
Trending Companies